Speak directly to the analyst to clarify any post sales queries you may have.
Companion animal pharmaceuticals encompasses the branch of veterinary medicine that is involved in the discovery, development, production, and marketing of drugs for pets, such as dogs, cats, and horses. These pharmaceuticals are designed to treat or prevent a wide range of conditions, from chronic diseases such as diabetes to acute infections or infestations, enhancing the health and well-being of companion animals. As companion animals become more integral to families, there is a rise in the demand for their healthcare. The prevalence of diseases transferable between animals and humans prompts more vigilant healthcare practices for companion animals. However, navigating through rigorous approval processes for new drugs can be time-consuming and costly, impeding the process of drug and pharmaceutical development. Research into cost-effective generic alternatives to branded medication can open up new market segments. Veterinary pharmaceutical companies are expanding into tailored treatment plans based on individual animal genetics, and biometrics can differentiate offerings. Moreover, there have been significant investments in the development of new vaccines and biologic treatments for various diseases.
Regional Insights
In the Americas, there is a high usage rate of companion animal pharmaceuticals, reflecting the substantial pet population and pet owners' inclination towards advanced veterinary care. The Americas demonstrates robust production capabilities, with many major pharmaceutical companies operating within the region. The APAC region is witnessing a growing adoption of companion animals, which is fuelling the demand for animal health products. However, the usage pattern is diversified with higher growth in countries such as Japan, Australia, and South Korea, compared to emerging markets where awareness and expenditure on animal health are still developing. Countries such as China and India are emerging as significant manufacturing hubs due to lower production costs and improving quality standards. There is also a notable investment in R&D, particularly in countries with a strong pharmaceutical industry in Asia. In Europe, there is a well-established market for companion animal pharmaceuticals characterized by stringent regulatory standards and a focus on safety and efficacy. The usage is marked by a high demand for chronic disease management products alongside preventive medications. The European region has well-established production facilities with a focus on high-quality standards compliant with the European Medicines Agency (EMA) regulations.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Companion Animal Pharmaceuticals Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Companion Animal Pharmaceuticals Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Companion Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Alivira Animal Health Limited, Ashish Life Science Pvt. Ltd., Boehringer Ingelheim International GmbH, Century Pharmaceuticals Ltd., Ceva Santé Animale, Chanelle Pharma, Dechra Pharmaceuticals PLC, Eco Animal Health Group PLC, Elanco Animal Health Incorporated, Endovac Animal Health, LLC, Hester Biosciences Limited, Hipra Laboratories, S.A., Indian Immunologicals Ltd., Kyoritsu Seiyaku Corporation, Lutim Pharma Pvt. Ltd., Meiji Group, Merck & Co. Inc., Neogen Corporation, Norbrook Laboratories Ltd., Orion Corporation, Phibro Animal Health Corporation, SkyEc Pharmaceuticals Private Limited, Stanex Drugs and Chemicals Pvt Ltd., Tianjin Ringpu Biotechnology Co., Ltd., Veko Care, Vetbiolix, Vetneeds Group, Virbac S.A., Zoetis Inc., and Zydus Animal Health.Market Segmentation & Coverage
This research report categorizes the Companion Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:- Product
- Analgesics
- Anti-infectives
- Anti-inflammatory
- Medicated Feed Additives
- Parasiticides
- Vaccines
- Indication
- Behavioral Disorders
- Dermatologic Diseases
- Infectious Diseases
- Orthopedic Diseases
- Pain
- Animal Type
- Cats
- Dogs
- Horses
- Distribution Channel
- Online Pharmacies
- Retail Pharmacies
- Veterinary Clinics
- Veterinary Hospitals
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as
- What is the market size and forecast of the Companion Animal Pharmaceuticals Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Companion Animal Pharmaceuticals Market?
- What are the technology trends and regulatory frameworks in the Companion Animal Pharmaceuticals Market?
- What is the market share of the leading vendors in the Companion Animal Pharmaceuticals Market?
- Which modes and strategic moves are suitable for entering the Companion Animal Pharmaceuticals Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
Companies Mentioned
- Alivira Animal Health Limited
- Ashish Life Science Pvt. Ltd.
- Boehringer Ingelheim International GmbH
- Century Pharmaceuticals Ltd.
- Ceva Santé Animale
- Chanelle Pharma
- Dechra Pharmaceuticals PLC
- Eco Animal Health Group PLC
- Elanco Animal Health Incorporated
- Endovac Animal Health, LLC
- Hester Biosciences Limited
- Hipra Laboratories, S.A.
- Indian Immunologicals Ltd.
- Kyoritsu Seiyaku Corporation
- Lutim Pharma Pvt. Ltd.
- Meiji Group
- Merck & Co. Inc.
- Neogen Corporation
- Norbrook Laboratories Ltd.
- Orion Corporation
- Phibro Animal Health Corporation
- SkyEc Pharmaceuticals Private Limited
- Stanex Drugs and Chemicals Pvt Ltd.
- Tianjin Ringpu Biotechnology Co., Ltd.
- Veko Care
- Vetbiolix
- Vetneeds Group
- Virbac S.A.
- Zoetis Inc.
- Zydus Animal Health
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 196 |
Published | March 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 14.73 Billion |
Forecasted Market Value ( USD | $ 28.21 Billion |
Compound Annual Growth Rate | 9.6% |
Regions Covered | Global |
No. of Companies Mentioned | 30 |